metaMe Health
Chicago
About metaMe Health
MetaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Funding stage: Seed
- Last round: Debt Financing (Mar 2024)
- Website: metamehealth.com
- Phone: 312-315-5935
Industries & Categories
Fitness, Health Care, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/metame-health-74821 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.